Bastian C.
- Country
- Germany
- Department
- Klinik für Geburtshilfe und Gynäkologie
Research Overview
- A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of BI 3820768 in Patients with Advanced Relapsed or Refractory Ovarian, Endometrial, or Germ Cell Tumors
- Phase III Randomized Trial of Platinum-Based Chemotherapy with Paclitaxel, Bevacizumab, and Atezolizumab in Metastatic, Persistent, or Recurrent Cervical Carcinoma
Data & Insights
Has run more than one trial at 3 of 57 partner sites.
Specializations
Gynecologic Oncology
The investigator specializes in treating advanced gynecologic malignancies, with particular focus on vulvar cancer and cervical carcinoma. Their research encompasses innovative therapeutic approaches for patients with metastatic, recurrent, and locally advanced disease states.
- Advanced Vulvar Cancer Management
- Cervical Cancer Treatment Strategies
- Metastatic Disease Therapy
Immunotherapy Applications
Their therapeutic focus includes the application of various immunotherapy agents in gynecologic cancers, including pembrolizumab and atezolizumab. The investigator explores combination approaches integrating immunotherapy with established treatment modalities.
- Targeted Immunotherapy
- Combination Treatment Protocols
- Advanced Cancer Immunology
Targeted Therapies
The investigator works with targeted therapeutic agents including lenvatinib and bevacizumab, exploring their efficacy in combination with other treatment modalities for gynecologic cancers not amenable to standard surgical or radiotherapy approaches.
- Anti-angiogenic Therapy
- Molecular Targeted Treatments
- Combination Therapy Strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.